Tag: Menopause / Postmenopause
Fezolinetant Safe, Effective for Moderate-to-Severe Menopause Hot Flashes
Benefits seen within days for both frequency and severity of symptoms
Risk for Depressive Symptoms Increased for Perimenopausal Women
Increased risk for depressive symptoms, diagnoses seen among perimenopausal, but not postmenopausal, women
Risk for Most Cardiovascular Diseases No Higher With Inflammatory Bowel Disease
CVD risk not increased in postmenopausal women with IBD, although risk for ischemic stroke may be elevated
Long-Term Study of Postmenopausal Women Does Not Support Many Preventive Therapies
Hormone therapy no aid for cardiovascular disease prevention, and calcium/vitamin D supplementation no aid for universal fracture prevention
Menopausal Hormone Therapy Use Beyond 65 Years Beneficial
Hormone therapy use linked to risk reductions in mortality
Endocrine, Vascular Processes Contribute to Cognitive Decline in Women
Earlier menopause and higher vascular risk synergistically associated with lower cognitive scores at follow-up
ACC: Coronary Artery Calcium Progression May Accelerate After Menopause
Authors say sharp increase in cardiovascular risk warrants more regular screening
Earlier Menopause Tied to Poorer Self-Perceived Work Ability
Additionally, it predicts lower recorded work participation and higher disability pension rate in subsequent years
Menopausal Hormone Therapy May Improve Depression Symptoms
Authors say more studies are needed to understand ideal timing window for treatment initiation
Female Reproductive Factors Linked to Risk for COPD
Age at menarche, number of children, number of miscarriages and stillbirths, age at natural menopause linked to COPD
